Helping to Ensure More Patients Have Access to Biomarker Testing
Biomarker Assist™ is comprised of two programs:
The Next Generation Sequencing (NGS) Affordability Program helps eligible patients (commercially or privately insured) with out-of-pocket costs for a comprehensive biomarker panel. This panel is for patients who have advanced or metastatic (stage IV) NSCLC, and it must include the KRAS gene.
The KRAS Single Gene Test (SGT) Program provides a KRAS Mutation Analysis at no cost to any eligible patient, regardless of a patient’s results and insurance. Patients will receive results from participating NeoGenomics Laboratories.
Visit www.BiomarkerAssist.com or contact 1-888-4ASSIST to learn more.
Supporting Patients From Every Angle
Amgen Nurse Navigators: a single point of contact who can help patients find the resources that are most important to them. Nurses Navigators provide personal support related to patients’ financial coverage and referrals to resources that may help with their emotional wellness.
Financial support options for any insurance type – even if you have none. The program can help patients understand how their medicine may be covered, and refer patients to programs that may be able to help them afford it.*
Referrals to resources for day-to-day living, like one-on-one counseling or local support groups
Answer questions about Amgen medicines
Visit www.AmgenAssist360.com or contact 1-888-4ASSIST to learn more.
*Resources include referrals to independent nonprofit patient assistance programs. Eligibility for resources provided by independent nonprofit patient assistance programs is based on the nonprofits’ criteria. Amgen has no control over these programs and provides referrals as a courtesy only.
Designed to assist patients who:
- Are uninsured
- Or the insurance plan excludes an Amgen medicine.
Sponsored by Amgen since 2001, ASNF provides Amgen medicines to qualifying patients at no cost.
For program information and additional eligbility critera, visit www.AmgenSafetyNetFoundation.com.